The Latest Cardiac and Vascular News
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage occurred. Data suggest that LT3001 has the potential to provide significant clinical benefit to patients in a longer treatment…
Remedy Robotics selected as Mission Thrombectomy’s exclusive robotics partner to broaden access to life-saving stroke treatment in the U.S. and across the world SAN FRANCISCO and WASHINGTON, Oct. 27, 2025 /PRNewswire/ — Remedy Robotics, Inc. (“Remedy”), a leading medical technology…
Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after onset) – a population with no approved drug options. Scp776 was safe and well-tolerated, with no increase in serious adverse events versus placebo. Scp776 leverages Silver Creek’s proprietary […]
-Financing supports execution of Phase 2b RAISE trial evaluating BB-031, an investigational reversible thrombolytic for acute ischemic stroke, and the planned Phase 1 study of BB-025, its fast-acting reversal agent- -Current CEO Richard Shea transitions to President and Chief Operating…
With several patients already enrolled in the study, PRISM PMR is designed to evaluate the Swoop® system’s clinical utility in the operating room. GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® […]
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the pioneer of deep clinical AI and the global leader in image-based decision support and workflow efficiencies, today announced that its Lumina 3D™ built on the Rapid Enterprise™ Platform has been named to TIME’s List of the Best Inventions of 2025, honoring 300 extraordinary innovations changing the […]
Partnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval Partnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval
Penumbra Inc., the world’s leading thrombectomy company, has secured CE Mark for its SwiftPAC™ neuro embolisation coil, which is part of the Swift™ Coil System and is now commercially available in Europe. Penumbra’s SwiftPAC coils are designed as a soft space-seeking “liquid metal” that conforms to the target vessel for dense […]
Stroke diagnostics innovator Wellumio seeks investors to transform stroke recovery Wellumio is transforming stroke care with portable brain scans to rapidly detect acute stroke that cuts diagnosis time and unlocks treatment in the ‘golden hour’ when every second counts WELLINGTON, New Zealand, September 16, 2025 – Wellumio, a New Zealand-based medical […]
KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation (“TMS”) clinics, and Advanced Behavioral Strategies (ABS).
